ctrl K

Watchlist Price Alert

TransCode Therapeutics In... (RNAZ)

NASDAQ: RNAZ · Real-Time Price · USD

0.34

-0.01 (-2.07%)

At close: May 14, 2025, 3:59 PM

0.32

-5.74%

After-hours: May 14, 2025, 07:49 PM EDT

TransCode Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	516.75K	98.61K	42.47K	n/a	n/a	n/a
Gross Profit	n/a	-516.75K	-98.61K	-42.47K	n/a	n/a	n/a
Operating Income	-15.66M	-19.42M	-18.67M	-6.15M	-726.6K	-456.87K	-384K
Interest Income	684.00	n/a	20.41K	664.00	136.00	34.00	68.92K
Pretax Income	-16.79M	-18.55M	-17.56M	-6.84M	-2.34M	-607.21K	-453.44K
Net Income	-16.79M	-18.55M	-35.13M	-6.94M	-2.74M	-764.14K	-453.44K
Selling & General & Admin	5.95M	6.64M	8.43M	3.4M	442.14K	230.56K	301.46K
Research & Development	9.71M	12.26M	10.23M	2.75M	284.46K	226.31K	82.53K
Other Expenses	n/a	n/a	-1.08M	-278.33K	n/a	n/a	n/a
Operating Expenses	15.66M	19.42M	17.59M	5.87M	726.6K	456.87K	384.52K
Interest Expense	26.81K	50.61K	17.56M	95.07K	394.57K	156.97K	n/a
Selling & Marketing Expenses	n/a	-7.15B	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	19.42M	17.59M	5.87M	726.6K	456.87K	384.52K
Income Tax Expense	n/a	n/a	17.56M	95.07K	394.44K	156.93K	-69.44K
Shares Outstanding (Basic)	356.12K	5.37K	16.22K	10.53K	7.98K	6.41K	192.21
Shares Outstanding (Diluted)	356.12K	5.37K	16.22K	10.53K	7.98K	6.41K	192.21
EPS (Basic)	-47.14	-3.45K	-73.19K	-648	-293.76	-72	-2.36K
EPS (Diluted)	-47.14	-3.45K	-1.08K	-648	-293.76	-72	-2.36K
EBITDA	-14.03M	-17.97M	-17.47M	-6.11M	n/a	n/a	-69.44K
EBIT	-14.57M	-18.49M	-17.56M	-6.15M	-726.6K	-450.25K	-384K
Depreciation & Amortization	534.86K	516.75K	98.61K	42.47K	726.6K	456.87K	384K